BioStem Technologies, Inc. is a pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue and the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Our proprietary approach, called Local MicroEnvironment Activation™ (LMA™), uses combinations of small molecules, cytokines, and growth factors (SMCGF) to activate the microenvironment within the body to create communication for repair in the tissue.
Since our founding in 2014, we’ve pursued a singular goal: growing into an innovative life sciences company with the power to change lives for the better. BioStem Technologies is a best-in-class manufacturer and distributor of perinatal tissue allografts. Our team has extensive scientific, medical and technical expertise in birth tissue processing for HCT/Ps.
In 2015 we founded our own 6000 square foot lab and manufacturing facility in Pompano Beach, Fl., doing business as BioStem Life Sciences.
Over 10,000 procedures have been conducted using BioStem products, with zero reported adverse events. Through our rigorous quality and proprietary production processes, we demonstrate our commitment to excellence and our focus on patient safety.